Recap: FibroGen Q4 Earnings

FibroGen FGEN reported its Q4 earnings results on Monday, February 26, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

FibroGen missed estimated earnings by -36.0%, reporting an EPS of $-0.57 versus an estimate of $-0.42.

Revenue was down $7.23 million from the same period last year.

Last quarter the company beat on EPS by $0.16 which was followed by a 1.0% drop in the share price the next day.

Here's a look at FibroGen's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.68	-0.72	-0.75	-0.94
EPS Actual	-0.52	-0.90	-0.81	-0.70
Revenue Estimate	36.84M	34.17M	31.84M	24.04M
Revenue Actual	40.13M	44.32M	36.16M	34.37M

To track all earnings releases for FibroGen visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar